Skip to main content
European Commission logo
Cancer Screening, Diagnosis and Care

EC-CvC working groups

EC-CvC is supported by an Expert Working Group and topic-specific groups composed of clinicians, epidemiologists, researchers, patient representatives and other experts who joined the initiative on a voluntary basis following a public call.

Members

To ensure the highest integrity and public confidence in its activities, the members disclose any circumstances, such as financial or professional interests or activities, that could give rise to a conflict of interest relevant to the project, on an annual basis.

The groups supporting the EC Initiative on Cervical Cancer are:

  • An expert working group, which acts as the decision-making body to finalise the recommendation and requirement proposals from the topic-specific groups.
  • Topic-specific groups, which work predominantly on specific healthcare questions and requirements with the support of independent experts. These topic-specific groups have a limited duration and provide systematic reviews to develop proposals for review by the working group.

Expert working group

Topic-specific groups

General population: Screening age-ranges, tests and intervals recommendations
DurationMembers
March 2024 - PresentAndrzej Nowakowski (Co-lead)    
Luciana Neamtiu (Co-lead)    
Marc Arbyn    
Johannes Berkhof
Mark Brincat
Joakim Dillner
Miriam Elfstrom
Urska Ivanus
Eliane Kellen
Paolo Giorgi Rossi
Noirin Russel
Eva-Maria Strömsholm
Treatment of cervical cancer requirements
DurationMembers
September 2024 - PresentAnne Hammer (Co-lead)    
Karin Sundstrom (Co-lead)
Viktor Cassar
Julia Gallwas
Kristina Hellman
Karlou Chrysoula
Katrine Fuglsang
Rosario Granados
Roberta Guiliani 
Lobna Ouldamer
Paula Cristina S.D. Sanches Pinto Alves
Eva-Maria Strömsholm
Vaccinated birth-cohorts recommendations
DurationMembers
May 2025 - Nov 2025Nathalie Broutet (Co-lead)    
Joakim Dillner (Co-lead)
Paolo Giorgi Rossi (Co-lead)
Marc Arbyn
Arantzazu Arrospide
Johannes Berkhof
Health outcome descriptors
DurationMembers
January 2024 - August 2024Luciana Neamtiu (Co-lead)
Andrzej Nowakowski (Co-lead)
Marc Arbyn
Joakim Dillner
Miriam Elfstrom
Urska Ivanus
Paolo Giorgi Rossi
Noirin Russel
Eva-Maria Strömsholm
Triage tests recommendations
DurationMembers
July 2025 - PresentPeter Hillemanns (Co-lead)
Noirin Russel (Co-lead)
Paola Armaroli
Xavier Carcopino-Tusoli
Urska Ivanus
Andrzej Nowakowski
Paolo Giorgi Rossi
Piret Veerus
Nicolas Wentzensen
Supportive care requirements (across all initiatives)
DurationMembers
November 2025 - PresentPierfrancesco Franco (Co-lead)
Csaba Laszlo Degi (Co-lead)
Mirjana Babamova  
Margarida Brito Goncalves  
Kimon Chatzistamatiou
Amanda Drury
Marcos Gomez Ruiz   
Pierre Martin Hirsch  
Helen Kelly  
Allesandro Laviano  
Hugo Ribeiro
Grainne Sheill 
Eva-Maria Stromsholm  
Andrea Stupalova  
Piret Veerus
Diagnosis and management of pre-cancer requirements
DurationMembers
December 2025 - PresentMargaret Cruickshank (Lead)
Mirjana Babamova
Anne Hammer
Fatjona Kamberi
Deirdre Lyons
Irmina Michalek
Andrzej Nowakowski
Jesper Hansen Bonde 
Eva-Maria Strömsholm
Epidemiological data
DurationMembers
August 2024 - February 2025Marc Arbyn
Paola Armaroli
Margaret Cruickshank
Miriam Elfstrom
Urska Ivanus
Noirin Russel
Anneli Uusküla
Invitation strategies recommendations (across all initiatives)
DurationMembers
December 2025 - PresentAmir Qaseem (Co-lead)
Paolo Giorgi Rossi (Co-lead)
Mirjana Babamova
Livia Giordano
Heather Rogers 
Zuleika Saz Parkinson   
Alan Smith
HPV tests recommendations
DurationMembers
January 2025 - PresentMiriam Elfstrom (Co-lead)
Sara Arroyo Muhr
Kate Cuschieri (Co-lead)
Peter Hillemanns
David Nuttall 
Paolo Giorgi Rossi 
Noirin Russel 
Nicolas Wentzensen

Meetings

  1. February 2026
    Expert Working Group

    Issue five recommendations on triage of HPV-positive women.

  2. November 2025
    Expert Working Group

    Issue four recommendations on age to start screening and screening intervals for HPV-vaccinated birth cohorts.
    Issue two recommendations on screening intervals for the general population.

  3. May 2025
    Expert Working Group

    Review and agree on general requirements for the Quality Assurance scheme.
    Preparatory work on screening indicators.

  4. February 2025
    Expert Working Group

    Issue recommendations on age to start and stop cervical screening for general population.
    Define decision thresholds for the magnitude of effects and management of positive cases.

  5. November 2024
    Expert Working Group

    Issue recommendations on age to start and stop cervical screening for general population.

  6. August 2024
    Expert Working Group

    Issue recommendations on cervical screening tests for the general population aged 50-69.

  7. February 2024
    Expert Working Group

    Reporting of results of the generation and prioritisation of healthcare questions and outcomes of interest.
    Definition of the essential care pathway.

  8. December 2023
    Expert Working Group

    Kick-off meeting

Documents

Original call for working group members
Declaration of interests for IARC/WHO experts
Guidance to IARC/WHO Experts for the Completion of DOI Forms
EC-CvC DOI procedure and summary - 2026